Admedus dominating in Europe., page-52

Back during webinar at the end of Feb WP said it would take 6 months to get things ticking over. August is month 6 and we are finally hearing that sales are breaking out and that we have had our best month YTD. Based on these comments logic would suggest this is $800k - $1M.

Because a large number off us are so in the red it seems that any positive news will never be enough unless it is a silver bullet that will turn the share price around in a day. Somewhat fair given the patience that has already been shown.

The change of financial year will be a real positive for the share price IMO. It gives AHZ an additional 6 months to lock in growth and hopefully profitability. This will mean the guidance given to the market for the new F18 will be a lot stronger than if the current 6 months were included.

Let's just hope significant traction is gained over the next 6 months with ADAPT and clarity has been provided around the immunotherapies division.

$3M minimum for ADAPT this quarter for me, if that's not achieved, I will start to jump on the nervous investor bandwagon.

GLTAH